Stockreport

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent [Read more]